Thermo Fisher Scientific Inc., US8835561023

Thermo Fisher stock: Q3 revenue reaches USD 12.14 billion for Thermo Fisher stock

Published on 10/21/2026 at 17:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Thermo Fisher lifted its 2026 outlook to USD 47.70-48.20 billion on October 21, 2026. Thermo Fisher stock costs EUR 624.20 on October 21, 2026.

Third-quarter results and outlook

Thermo Fisher reported USD 12.14 billion of third-quarter revenue on October 21, 2026.
The company lifted its fiscal 2026 revenue outlook to USD 47.70 billion-USD 48.20 billion on October 21, 2026.
Thermo Fisher stock costs EUR 624.20 at Lang & Schwarz on October 21, 2026 at 5:50 p.m. CEST.
Thermo Fisher expects to report fourth-quarter and full-year results on February 2, 2027.

Draufsicht auf Aktienzertifikat, ISIN-Karte, Pipette und Reagenzgläser auf weißer Fläche — Flatlay-Arrangement repräsentiert Thermo Fisher Sci. US8835561023 mit Aktienzertifikat, ISIN-Karte und Laborutensilien auf weißem Untergrund, Illustration mit AI erstellt.

Thermo Fisher Scientific Inc. (ISIN US8835561023) reported third-quarter revenue of USD 12.14 billion on October 21, 2026, up 9.00 percent from the year-earlier period, while adjusted earnings per share rose 15.00 percent to USD 6.68. Borsa Italiana reported the figures on the results date. At 5:50 p.m. CEST, Thermo Fisher stock was trading at EUR 624.20 at Lang & Schwarz on October 21, 2026.

Full-year outlook moves higher

Thermo Fisher raised its fiscal 2026 revenue outlook to USD 47.70 billion-USD 48.20 billion and its adjusted earnings-per-share outlook to USD 25.13-USD 25.43. The updated revenue range implies 7.00 percent-8.00 percent growth from 2025, while the earnings range implies 10.00 percent-11.00 percent growth. Benzinga reported the revised outlook on October 21, 2026.

Stock stays near its yearly high

The primary-market quote was USD 702.16 on the NYSE at 11:55 a.m. EDT on October 21, 2026. That price stood 0.26 percent below the USD 704.00 52-week high and above the USD 435.27 low. Thermo Fisher's market capitalization was USD 259.6 billion, and trading volume reached 1,654,784 shares at that time.

Valuation and the next results date

The stock carried a trailing price-to-earnings ratio of 37.00 on October 21, 2026. The next scheduled results date is February 2, 2027, when Thermo Fisher plans to discuss its fourth-quarter and full-year performance. Benzinga carried the date from the earnings call.

What the quarter changes

The results add a stronger operating picture to the valuation. Revenue growth reached 9.00 percent in the third quarter, while adjusted operating income increased 15.00 percent to USD 2.97 billion and the adjusted operating margin expanded to 24.50 percent. The margin benefited from productivity and a USD 60.00 million tariff-refund impact on adjusted operating income, according to the earnings-call transcript.

Stock position after the results

Thermo Fisher combines higher near-term expectations with a valuation that remains tied to execution in pharma services, analytical instruments and laboratory products. The company said fiscal 2026 free cash flow should reach USD 7.00 billion-USD 7.50 billion, giving investors another operating measure alongside revenue and adjusted earnings.

Thermo Fisher stock was trading at EUR 624.20 at Lang & Schwarz on October 21, 2026 at 5:50 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Thermo Fisher stock.